Covid vaccine makers Pfizer, J&J notch high brand marks amid overall still-strong pharma industry rep: Harris Poll
Can the pharma industry hold onto its pandemic-minted positive reputation? So far so good, according to the Harris Poll’s latest data. The industry seems to have stabilized positive opinions in the US, now leveling off in the mid-50 percent ranges, data from the Harris Poll’s most recent December survey reveal.
Meanwhile, the global picture is even sunnier. The pharma industry notched a 59% overall positive industry sentiment, ahead of financial services (51%) and insurance (47%), and not that far behind typical favorites like consumer packaged goods (64%) and retail (66%).
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters